Search Results - gai+yan

1 Results

Sort By:

Use of Histone Acetyltransferase Inhibitors as Novel Anti-cancer Therapies

C10974: Anti-Cancer Therapeutic BiomarkerNovelty: This technology includes a novel histone acetyltransferase (HAT) inhibitor as a therapeutic and biomarker for a vast scope of cancers.Value Proposition: Acetylation and deacetylation of histone protein lysine residues are a major mechanism for cellular regulation and are implicated in a wide variety...

Published: 3/13/2025 | Inventor(s): Philip Cole, Gai Yan, Erin Bowers, Rhoda Alani

Keywords(s): Acetylation, Antagonists/Inhibitors, Biomarker, Cancers, Clinical Diagnostics, Disease Indication, Epigenetic, In Vitro Diagnostics (Old), Non-novel, Off-the-shelf, Predicted Novelty, Single, Small Molecules, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities, Technology Classifications > Diagnostics > Biomarkers